BCB Bancorp (BCBP) Q1 2025 earnings summary

Executive summary

• Reported net loss of $8.3 million for Q1 2025, compared to net income of $5.9 million in Q1 2024 and $3.3 million in Q4 2024, driven by a surge in credit loss provisions, especially for cannabis and Business Express loans.

• Loss per diluted share was ($0.51), down from $0.16 in Q4 2024 and $0.32 in Q1 2024.

• Total assets decreased 3.5% to $3.47 billion, mainly due to declines in net loans and cash.

• Deposits fell 2.3% to $2.69 billion, with a notable reduction in brokered deposits offset by increases in other deposit categories.

• Credit risk team strengthened and risk ratings adjusted to reflect current market realities.

Financial highlights

• Net interest income decreased 4.9% year-over-year to $22.0 million; net interest margin improved to 2.59% from 2.50% year-over-year.

• Provision for credit losses surged to $20.8 million from $2.1 million in Q1 2024 and $4.2 million in Q4 2024, mainly due to a $13.7 million reserve for a large cannabis loan and $3.1 million for Business Express loans.

• Non-interest income declined to $1.8 million from $2.1 million, primarily due to lower gains on equity securities and BOLI income.

• Non-interest expense was $14.7 million, down 1.2% year-over-year, with lower regulatory assessments offset by higher salaries.

• Allowance for credit losses increased to $51.5 million (1.73% of gross loans), up from $34.8 million (1.15%) at year-end 2024.

Outlook and guidance

• Management expects to have sufficient liquidity to meet loan commitments and maintain adequate capital, with significant borrowing capacity available.

• The company remains well-capitalized, exceeding all regulatory capital requirements.

• Management remains focused on proactive risk management and capital strength.

• Forward-looking statements highlight risks from macroeconomic headwinds, inflation, global conflicts, and regulatory changes.